References
Singh BN: Acute management of ventricular arrhythmias: role of antiarrhythmic agents. Pharmacotherapy 1977, 2(Pt 2):56S-64S.
Desai AD, Chun S, Sung RJ: The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med 1997, 127:294–303.
Echt DS, Liebson PR, Mitchell LB, et al., and the CAST investigators: Mortality and Morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781–788.
Waldo AL, Camm AJ, deRuyter H, et al., for the SWORD investigators: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators. Survival with oral d-sotalol. Lancet 1996, 348:7–12.
Friedman PL, Stevenson WG: Proarrhythmia. Am J Cardiol 1998, 82:50N-58N.
The AVID investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576–1583.
Cappato R: Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Am J Cardiol 1999, 83(5B):68D-73D.
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study). Am J Cardiol 1991, 67:578–584.
The ESVEM Investigators: Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. Circulation 1993, 87:323–329.
Haverkamp W, Martinez-Rubio A, Hief C, et al.: Efficacy and safety of dl-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. J Am Coll Cardiol 1997, 30:487–495.
Pacifico A, Hohnloser SH, Williams JH, et al.: Prevention of Implantable-Defibrillator shocks by treatment with sotalol. N Engl J Med 1999, 340:1855–1862.
Seidl K, Hauer B, Schwick NG, et al.: Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol 1998, 82:744–748.
Klein LS, Shih HT, Hackett FK, et al.: Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992, 85:1666–1674.
Stevenson WG, Khan H, Sager P, et al.: Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993, 88:1647–1670.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mehta, D. Redefining the role of antiarrhythmic drugs in the management of ventricular arrhythmias. Curr Cardiol Rep 1, 265–267 (1999). https://doi.org/10.1007/s11886-999-0048-2
Issue Date:
DOI: https://doi.org/10.1007/s11886-999-0048-2